Clinical Trials
4 trialsNCT03170141 2026-04-24
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Shenzhen Geno-Immune Medical Institute
Phase 1 Enrolling by invitation
NCT06300502 2026-04-22
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
Massachusetts General Hospital
Phase 1 Enrolling by invitation
NCT06896110 2025-06-26
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
University of Iowa
Phase 1 Enrolling by invitation
NCT06616727 2024-09-27
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Shanghai Simnova Biotechnology Co.,Ltd.
Phase 1 Enrolling by invitation